STAAR Surgical (STAA) Competitors

National Vision (NASDAQ:EYE) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, valuation, profitability, dividends, risk, media sentiment and institutional ownership.

Do insiders and institutionals have more ownership in EYE or STAA?

96.7% of STAAR Surgical shares are held by institutional investors. 2.3% of National Vision shares are held by company insiders. Comparatively, 1.0% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Which has stronger earnings & valuation, EYE or STAA?

STAAR Surgical has lower revenue, but higher earnings than National Vision. National Vision is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
National Vision	$2.13B	0.56	-$65.90M	-$0.92	-16.40
STAAR Surgical	$322.42M	6.33	$21.35M	$0.31	133.97

Which has more volatility and risk, EYE or STAA?

National Vision has a beta of 1.47, indicating that its share price is 47% more volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500.

Does the MarketBeat Community believe in EYE or STAA?

STAAR Surgical received 32 more outperform votes than National Vision when rated by MarketBeat users. However, 65.89% of users gave National Vision an outperform vote while only 56.10% of users gave STAAR Surgical an outperform vote.

Company	Underperform	Outperform
National Vision	Outperform Votes 253 65.89%	Underperform Votes 131 34.11%
STAAR Surgical	Outperform Votes 285 56.10%	Underperform Votes 223 43.90%

Do analysts recommend EYE or STAA?

National Vision currently has a consensus price target of $19.60, indicating a potential upside of 29.89%. STAAR Surgical has a consensus price target of $47.13, indicating a potential upside of 13.47%. Given STAAR Surgical's higher possible upside, equities analysts clearly believe National Vision is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
National Vision	0 Sell rating(s)	5 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
STAAR Surgical	0 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.40

Is EYE or STAA more profitable?

STAAR Surgical has a net margin of 4.69% compared to STAAR Surgical's net margin of -3.44%. National Vision's return on equity of 6.83% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
National Vision	-3.44%	3.47%	1.33%
STAAR Surgical	4.69%	6.83%	5.45%

Does the media prefer EYE or STAA?

In the previous week, National Vision had 8 more articles in the media than STAAR Surgical. MarketBeat recorded 11 mentions for National Vision and 3 mentions for STAAR Surgical. National Vision's average media sentiment score of 0.74 beat STAAR Surgical's score of 0.61 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
National Vision	3 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

STAAR Surgical beats National Vision on 12 of the 18 factors compared between the two stocks.